Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingxiang Teng

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Nature Genetics|September 26, 2017
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promotersRobert T Nakayama, John L Pulice, Alfredo M Valencia, et al.
The Journal of Clinical Investigation|May 19, 2026
Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancerRavi Bandaru, Hailu Fu, Haizi Zheng, et al.
Research Square|August 13, 2025
ShinyEvents: harmonizing longitudinal data for real world survival estimationAlyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
NPJ Precision Oncology|January 12, 2026
ShinyEvents: harmonizing longitudinal data for real-world survival estimationAlyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
Research Square|May 5, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple MyelomaRafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Cancer Research|June 3, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple MyelomaRafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Nature Genetics|September 26, 2017
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promotersRobert T Nakayama, John L Pulice, Alfredo M Valencia, et al.
The Journal of Clinical Investigation|May 19, 2026
Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancerRavi Bandaru, Hailu Fu, Haizi Zheng, et al.
Research Square|August 13, 2025
ShinyEvents: harmonizing longitudinal data for real world survival estimationAlyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
NPJ Precision Oncology|January 12, 2026
ShinyEvents: harmonizing longitudinal data for real-world survival estimationAlyssa Obermayer, Joshua Davis, Divya Priyanka Talada, et al.
Research Square|May 5, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple MyelomaRafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Cancer Research|June 3, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple MyelomaRafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Pageof 8